Estimated Acquisition Cost Differences between Fixed and Simulated Body Weight-Based Nivolumab Dosing Using Real-World Claims Data in Japan.

Opdivo (nivolumab) - Ono Pharmaceutical, BMS

http://www.ncbi.nlm.nih.gov/pubmed/42753082

Ai Ohnishi; Rikuto Masuda; Tomoaki Yoshimura; Tomohiko Harada; Tomoya Sugimoto; Yoshihiro Noguchi

Sep 18, 2026